Tests
The goals with testing are to diagnose APS and to distinguish it from other causes of symptoms and complications. Not everyone who has antiphospholipid antibodies has symptoms or complications. Therefore, a diagnosis of APS is made based upon both clinical signs and the presence of autoantibodies. At least one clinical sign and one autoantibody must be present. The following consensus guidelines are used:
| Revised Classification Criteria for the Antiphospholipid Antibody Syndrome* | |
| Clinical criteria | Laboratory criteria |
|
Vascular thrombosis:
Pregnancy complications:
|
Positive test for one of the autoantibodies must be present on 2 or more occasions at least 12 weeks apart:
|
| *Established in 2006 by the 11th International Congress on Antiphospholipid Antibodies | |
Laboratory Tests
Blood tests that are used to detect the presence of autoantibodies include:
- Lupus anticoagulant testing (e.g., DRVVT)
- Cardiolipin antibodies
- Beta2 glycoprotein I (β2GP1) antibodies
Other tests that may be ordered include:
- Activated partial thromboplastin time (PTT, to evaluate blood clotting)
- Complete blood count (CBC, to evaluate blood cells and platelets)
- A variety of additional tests to evaluate other causes for a person's symptoms, such as 1:1 Mix study (dilute PTT) to detect lupus anticoagulant activity
Non-Laboratory Tests
Imaging scans may be performed to confirm a thrombotic episode, to locate a blood clot, evaluate organ damage, and to monitor a fetus. These may include:
- CT scan
- MRI
- Ultrasounds to detect blood clots and to monitor fetal health and growth
- Echocardiograph to detect heart valve abnormalities that can occur with APS
For more on these, see the web site Radiologyinfo.org.


















